
|Videos|December 19, 2015
Benefits and Risks of Off-Label Use of NOACs
Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses the benefits and risks of off-label use of new oral anticoagulants.
Advertisement
Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses the benefits and risks of off-label use of new oral anticoagulants.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Understanding Myelofibrosis and the Central Role of JAK Pathway Dysregulation
3
Pharmacists’ Expanding Role in Optimizing Oral Endocrine and Targeted Breast Cancer Therapies
4
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
5




































































































































































































